MedTrace Logo

Early Induced Hypernatremia for the Prevention and Management of Brain Edema

NCT02798601 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-09-22

No results posted yet for this study

Summary

The purpose of this study is to estimate the effect of an early induced hypernatremia protocol (150-155 milliequivalent/L) versus normonatremia plus mannitol (135 - 145 milliequivalent/L) in terms of neurologic outcome in patients with severe traumatic brain injury managed at critical care unit.

Conditions

  • Head Trauma

Interventions

OTHER

Hypernatremia

Serum Sodium goal: 150 - 155 milliequivalent/L.

Sponsors & Collaborators

  • CES University

    collaborator OTHER

  • Hospital Pablo Tobón Uribe

    lead OTHER

Principal Investigators

  • Juan C Lopez de Mesa, MD · Hospital Pablo Tobon Uribe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2017-01-18
Completion
2018-01-18

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798601 on ClinicalTrials.gov